HMOX1 and Parkinson disease: Conversely, Nrf2 modulators like dimethyl fumarate and sulforaphane have demonstrated endogenous activation of antioxidant enzymes (GPx, SOD, HO-1), exhibiting neuroprotective effects in AD and PD models [174].